N. E. Rosenstein, B. A. Perkins, D. S. Stephens, T. Popovic, and J. M. Hughes, Meningococcal disease, N Engl J Med, vol.344, issue.18, pp.1378-88, 2001.

P. Kriz, H. Wieffer, K. Holl, M. Rosenlund, S. Budhia et al., Changing epidemiology of meningococcal disease in Europe from the mid-20th to the early 21st Century, Expert Rev Vaccines, vol.10, issue.10, pp.1477-86, 2011.

L. H. Harrison, C. L. Trotter, and M. E. Ramsay, Global epidemiology of meningococcal disease, Vaccine, vol.27, issue.2, pp.51-63, 2009.

S. A. Halperin, J. A. Bettinger, B. Greenwood, L. H. Harrison, J. Jelfs et al., The changing and dynamic epidemiology of meningococcal disease, Vaccine, vol.30, issue.2, pp.26-36, 2012.

W. Hellenbrand, H. Claus, S. Schink, U. Marcus, O. Wichmann et al., Risk of invasive meningococcal disease in men who have sex with men: lessons learned from an outbreak in Germany, PloS one, vol.11, issue.8, p.160126, 2016.

A. Ridpath, S. K. Greene, B. F. Robinson, and D. Weiss, Meningococcal investigation Team. Risk factors for serogroup C meningococcal disease during outbreak among men who have sex with men, Emerg Infect Dis, vol.21, issue.8, pp.1458-61, 2015.

S. N. Ladhani, K. Beebeejaun, J. Lucidarme, H. Campbell, S. Gray et al., Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales, Clin Infect Dis, vol.60, issue.4, pp.578-85, 2015.

, The National Institute for Public Health and the Environment. The National Immunisation Programme in the Netherlands. Surveillance and Developments in 2015-16, 2016.

C. L. Trotter and M. E. Ramsay, Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines, FEMS Microbiol Rev, vol.31, issue.1, pp.101-108, 2007.

S. J. Gray, C. L. Trotter, M. E. Ramsay, M. Guiver, A. J. Fox et al., Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit, J Med Microbiol, vol.55, pp.887-96, 2006.

M. W. Bijlsma, V. Bekker, M. C. Brouwer, L. Spanjaard, D. Van-de-beek et al., Epidemiology of invasive meningococcal disease in the Netherlands, 19602012: an analysis of national surveillance data, Lancet Infect Dis, vol.14, issue.9, pp.805-817, 2014.

, European Centre of Disease Prevention and Control. Vaccine Schedule

E. Network, Invasive Neisseria meningitidis in Europe, 2006.

A. Larrauri, R. Cano, M. Garcia, and S. Mateo, Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain, Vaccine, vol.23, issue.32, pp.4097-100, 2005.

R. Borrow, R. Abad, C. Trotter, F. R. Van-der-klis, and J. A. Vazquez, Effectiveness of meningococcal serogroup C vaccine programmes, Vaccine, vol.31, issue.41, pp.4477-86, 2013.
DOI : 10.1016/j.vaccine.2013.07.083

H. Campbell, N. Andrews, R. Borrow, C. Trotter, and E. Miller, Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity, Clin Vaccine Immunol, vol.17, issue.5, pp.840-847, 2010.

M. Garrido-estepa, L. Herruzo, R. Cano, and R. , Changes in meningococcal C epidemiology and vaccine effectiveness after vaccine introduction and schedule modification, Vaccine, vol.32, issue.22, pp.2604-2613, 2014.
DOI : 10.1016/j.vaccine.2014.03.010

W. Hellenbrand, J. Elias, O. Wichmann, M. Dehnert, M. Frosch et al., Epidemiology of invasive meningococcal disease in Germany, 2002-2010, and impact of vaccination with meningococcal C conjugate vaccine, J Infect, vol.66, issue.1, pp.48-56, 2013.

M. Broker, S. Emonet, C. Fazio, S. Jacobsson, M. Koliou et al., Meningococcal serogroup Y disease in Europe continuation of high importance in some European regions in 2013, Hum Vaccin Immunother, 2015.
URL : https://hal.archives-ouvertes.fr/pasteur-02063970

J. Wise, Teenagers in England to be vaccinated against meningitis group W, BMJ, vol.350, p.1486, 2015.

, European Centre of Disease Prevention and Control. The Surveillance Atlas of Infectious Diseases

, Commission implementing decision of 8 August 2012 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/ 98/EC of the European Parliament, 2012.

J. D. Mooney, P. Christie, C. Robertson, and S. C. Clarke, The impact of meningococcal serogroup C conjugate vaccine in Scotland, Clin Infect Dis, vol.39, issue.3, pp.349-56, 2004.

P. Stefanelli, C. Fazio, A. Neri, S. Boros, G. Renna et al., Changing epidemiology of Infant Meningococcal Disease after the introduction of meningococcal serogroup C vaccine in Italy, Vaccine, vol.33, issue.31, pp.3678-81, 2006.

C. De-waure, A. Miglietta, D. Nedovic, G. Mereu, and W. Ricciardi, Reduction in Neisseria meningitidis infection in Italy after Meningococcal C conjugate vaccine introduction: a time trend analysis of 1994-2012 series, Hum Vaccin Immunother, vol.12, issue.2, pp.467-73, 2016.

L. Aubert, M. Taha, N. Boo, L. Strat, Y. Deghmane et al., Serogroup C invasive meningococcal disease among men who have sex with men and in gay-oriented social venues in the Paris region, Euro Surveill, vol.20, issue.3, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-02060707

P. Stefanelli, A. Miglietta, P. Pezzotti, C. Fazio, A. Neri et al., Increased incidence of invasive meningococcal disease of serogroup C/clonal complex 11, Euro Surveill, vol.21, issue.12, 2015.

M. Garrido-estepa, O. G. Nunez, I. Leon-gomez, R. Cano, and R. Herruzo,

, Meningococcal C conjugate age-dependant long-term loss of effectiveness, Vaccine, vol.33, pp.2221-2228, 2015.

C. L. Trotter, N. J. Andrews, E. B. Kaczmarski, E. Miller, and M. E. Ramsay, Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction, Lancet, vol.364, issue.9431, pp.365-372, 2004.

M. C. Maiden, A. B. Ibarz-pavon, R. Urwin, S. J. Gray, N. J. Andrews et al., Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity, J Infect Dis, vol.197, issue.5, pp.737-780, 2008.

M. E. Ramsay, N. J. Andrews, C. L. Trotter, E. B. Kaczmarski, and E. Miller, Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis, BMJ, vol.326, issue.7385, pp.365-371, 2003.

P. Krizova, M. Musilek, Z. Vackova, Z. Becvarova, and J. Kozakova, Sequencing analysis of the antigens included in the four-component vaccine against serogroup B meningococcus in Czech isolates of Neisseria meningitidis from, Epidemiol Mikrobiol Imunol, vol.63, issue.1, pp.61-69, 2007.

J. Lucidarme, K. J. Scott, R. Ure, A. Smith, D. Lindsay et al., An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup W strain, Scotland and Sweden, Euro Surveill, vol.21, issue.45, 2015.

A. Takla, O. Wichmann, P. Carrillo-santisteve, S. Cotter, D. Levy-bruhl et al., Characteristics and practices of National Immunisation Technical Advisory Groups in Europe and potential for collaboration, Euro Surveill, vol.20, issue.9, 2014.

U. Vogel, M. K. Taha, J. A. Vazquez, J. Findlow, H. Claus et al., Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment, Lancet Infect Dis, vol.13, issue.5, pp.416-441, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-02093031

D. A. Kafetzis, K. N. Stamboulidis, G. Tzanakaki, K. Kremastinou, J. Skevaki et al., Meningococcal group C disease in Greece during 1993-2006: the impact of an unofficial single-dose vaccination scheme adopted by most paediatricians, Clin Microbiol Infect, vol.13, issue.5, pp.550-552, 2007.